Common treatment measures, such as hormone therapies or receptor-targeting drugs, are not effective for triple-negative breast cancer, otherwise known as TNBC.
Common treatment measures, such as hormone therapies or receptor-targeting drugs, are not effective for triple-negative breast cancer, otherwise known as TNBC.